How to diagnose and treat focal therapy failure and recurrence?
Authors:
- Eric BarretEBEric Barret
- Kadi-Ann Harvey-BryanKHKadi-Ann Harvey-Bryan
- Rafael Sanchez-SalasRSRafael Sanchez-Salas
- Francois RozetFRFrancois Rozet
- Marc GalianoMGMarc Galiano
- Xavier CathelineauXCXavier Cathelineau
- 1 May 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Urology
- Vol. 24 (3) , 241-246
Abstract
Focal therapy presents an alternative option for disease-targeted therapy while preserving erectile and urinary function without compromising oncological outcome. Such treatment, which preserves normal prostate parenchyma, presents a clinical challenge to the urologist, as typical disease surveillance parameters are not as reliable in post-ablation follow-up. We propose an integrated approach to post-ablation surveillance to identify treatment failure as well as recurrence. Post-ablation prostate-specific antigen kinetics, imaging based on multiparametric MRI and control biopsies are the tools currently used to follow patients after focal therapy. Good treatment response is indicated by a negative control biopsy, absence of persistent lesion on post-treatment imaging and a reduction in prostate-specific antigen of at least 50%. When histological evidence of therapeutic failure or recurrence is present, different options of management may be proposed to the patient including active surveillance, focal salvage therapy or radical salvage treatment, depending on the characteristics of the lesion found. A recommended post-ablation surveillance protocol is presented as well as a discussion of management strategies based on the data currently available.Keywords
This publication has 25 references indexed in Scilit:
- Focal therapy of prostate cancer: energies and proceduresUrologic Oncology: Seminars and Original Investigations, 2013
- Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development studyThe Lancet Oncology, 2012
- Focal cryotherapy for localized prostate cancer: a report from the national Cryo On‐Line Database (COLD) RegistryBJU International, 2011
- An Evaluation of Patient Selection Criteria on Predicting Progression-Free Survival After Primary Focal Unilateral Nerve-Sparing Cryoablation for Prostate CancerThe Cancer Journal, 2010
- Focal Therapy in Prostate Cancer—Report from a Consensus PanelJournal of Endourology, 2010
- Image Guided Photothermal Focal Therapy for Localized Prostate Cancer: Phase I TrialJournal of Urology, 2009
- The “male lumpectomy”: Focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-upUrologic Oncology: Seminars and Original Investigations, 2008
- Focal Cryosurgery Followed by Penile Rehabilitation as Primary Treatment for Localized Prostate Cancer: Initial ResultsUrology, 2007
- Focal Cryosurgery: Encouraging Health Outcomes for Unifocal Prostate CancerUrology, 2007
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006